Cargando…

Circulating Protein Biomarkers in Systemic Sclerosis Related Pulmonary Arterial Hypertension: A Review of Published Data

Pulmonary arterial hypertension (PAH) develops in 7–12% of patients with systemic sclerosis (SSc) and is associated with a 3 year survival of 52%. Early detection by screening is therefore recommended for all patients with SSc. Historically, screening has been performed using echocardiography and me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hickey, Peter M., Lawrie, Allan, Condliffe, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997816/ https://www.ncbi.nlm.nih.gov/pubmed/29928643 http://dx.doi.org/10.3389/fmed.2018.00175

Ejemplares similares

An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers
por: Santos-Gomes, Joana, et al.
Publicado: (2022)

Pathophysiology and Diagnosis of Pulmonary Hypertension Due to Left Heart Disease
por: Charalampopoulos, Athanasios, et al.
Publicado: (2018)

Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort
por: Bauer, Yasmina, et al.
Publicado: (2021)

Pulmonary Artery Denervation Reduces Pulmonary Artery Pressure and Induces Histological Changes in an Acute Porcine Model of Pulmonary Hypertension
por: Rothman, Alexander M.K., et al.
Publicado: (2015)

Connective tissue disease-associated pulmonary arterial hypertension
por: Condliffe, Robin, et al.
Publicado: (2015)

Clinical features of pulmonary arterial hypertension associated with systemic sclerosis
por: Tuhy, Tijana, et al.
Publicado: (2023)

Imaging and Risk Stratification in Pulmonary Arterial Hypertension: Time to Include Right Ventricular Assessment
por: Alandejani, Faisal, et al.
Publicado: (2022)

Incremental Shuttle Walking Test Distance Is Reduced in Patients With Pulmonary Hypertension in World Health Organisation Functional Class I
por: Billings, Catherine G., et al.
Publicado: (2018)

Pulmonary hypertension phenotypes in patients with systemic sclerosis
por: Haque, Ashraful, et al.
Publicado: (2021)

Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension
por: Diekmann, Franziska, et al.
Publicado: (2021)

Current Understanding of Circulating Biomarkers in Pulmonary Hypertension Due to Left Heart Disease
por: Todd, Noah, et al.
Publicado: (2020)

Peripheral Microangiopathy Changes in Pulmonary Arterial Hypertension Related to Systemic Sclerosis: Data From a Multicenter Observational Study
por: Giuggioli, Dilia, et al.
Publicado: (2022)

Screening strategies for pulmonary arterial hypertension
por: Kiely, David G, et al.
Publicado: (2019)

Editorial: Pulmonary Hypertension: Mechanisms and Management, History and Future
por: Thompson, A. A. Roger, et al.
Publicado: (2020)

Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility
por: Chin, Matthew, et al.
Publicado: (2018)

TIMP-1: A Circulating Biomarker for Pulmonary Hypertension Diagnosis Among Chronic Obstructive Pulmonary Disease Patients
por: He, Wenjun, et al.
Publicado: (2022)

Computational platform for doctor–artificial intelligence cooperation in pulmonary arterial hypertension prognostication: a pilot study
por: Kheyfets, Vitaly O., et al.
Publicado: (2023)

Elevated Plasma CXCL12α Is Associated with a Poorer Prognosis in Pulmonary Arterial Hypertension
por: McCullagh, Brian N., et al.
Publicado: (2015)

Right Ventricle to Pulmonary Artery Coupling Predicts the Risk Stratification in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
por: Lai, Jinzhi, et al.
Publicado: (2022)

Selenium and Copper as Biomarkers for Pulmonary Arterial Hypertension in Systemic Sclerosis
por: Sun, Qian, et al.
Publicado: (2020)

Adults’ experiences of living with pulmonary hypertension: a thematic synthesis of qualitative studies
por: Rawlings, Gregg Harry, et al.
Publicado: (2020)

Pulmonary Arterial Stiffness: An Early and Pervasive Driver of Pulmonary Arterial Hypertension
por: Sun, Wei, et al.
Publicado: (2018)

Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension
por: Wuttge, Dirk M, et al.
Publicado: (2021)

Inflammasome Activation in Pulmonary Arterial Hypertension
por: Foley, Anna, et al.
Publicado: (2022)

Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension
por: Condliffe, Robin, et al.
Publicado: (2012)

Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response
por: Goh, Ze Ming, et al.
Publicado: (2022)

Pulmonary Circulation with Chronic Thromboembolic Pulmonary Hypertension
por: Fukamachi, Daisuke, et al.
Publicado: (2022)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)

A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosis
por: Swift, Andrew J, et al.
Publicado: (2020)

Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
por: Rice, Lisa M., et al.
Publicado: (2018)

Effect of dual pulmonary vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease: a retrospective analysis
por: Monfredi, Oliver, et al.
Publicado: (2016)

Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study
por: Rhodes, Christopher J, et al.
Publicado: (2017)

Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension
por: Lewis, Robert A., et al.
Publicado: (2020)

Arrhythmic Burden and Outcomes in Pulmonary Arterial Hypertension
por: Middleton, Jennifer T., et al.
Publicado: (2019)

Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
por: Rice, Lisa M., et al.
Publicado: (2022)

Effects of Exercise Training on Circulating Biomarkers of Endothelial Function in Pulmonary Arterial Hypertension
por: Rodríguez-Chiaradía, Diego A., et al.
Publicado: (2023)

The Role of Neutrophils and Neutrophil Elastase in Pulmonary Arterial Hypertension
por: Taylor, Shalina, et al.
Publicado: (2018)

Transitioning Between Prostanoid Therapies in Pulmonary Arterial Hypertension
por: Pan, Irene Z., et al.
Publicado: (2020)

Use of Pulmonary Arterial Hypertension Therapies in Patients with a Fontan Circulation: Current Practice Across the United Kingdom
por: Constantine, Andrew, et al.
Publicado: (2021)

Right Ventricular Adaptation Assessed Using Cardiac Magnetic Resonance Predicts Survival in Pulmonary Arterial Hypertension
por: Goh, Ze Ming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ntk3d4b5410ic4mg1s83fks61e